Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
73%
Ph phase_4
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(7)
Completed(3)
Other(1)

Detailed Status

Not yet recruiting4
Completed3
Recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (27.3%)
N/A8 (72.7%)

Trials by Status

completed327%
not_yet_recruiting436%
active_not_recruiting19%
recruiting218%
unknown19%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11